The field of organ transplantation is advancing rapidly, with Advanced Therapy Medicinal Products (ATMPs) emerging as a groundbreaking avenue for improving transplant outcomes. These innovative therapies offer new therapeutic possibilities and raise important questions regarding their clinical implementation.
To proactively address this evolving landscape, the European Society for Organ Transplantation (ESOT) has established a taskforce on ATMPs with the aim of promoting global health and access to advanced therapies. The task force was officially launched during the most recent EPITA Symposium.
The taskforce is led by:
Ekaterine Berishvili, Geneva, Switzerland
Olivier Thaunat, Lyon, France